ras and p53 genes in male breast cancer

被引:0
|
作者
Dawson, PJ
Schroer, KR
Wolman, SR
机构
[1] UNIV S FLORIDA,JAMES A HALEY VET ADM HOSP,DEPT PATHOL & LAB MED,TAMPA,FL 33612
[2] UNIV S FLORIDA,H LEE MOFFITT CANC CTR,TAMPA,FL 33682
[3] GEORGE WASHINGTON UNIV,SCH MED,WASHINGTON,DC 20052
[4] ONCOR INC,GAITHERSBURG,MD
关键词
male breast cancer; p53 suppressor gene; ras oncogene;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We have studied the robs of Ki-ras oncogene and p53 tumor suppressor gene in a series of 20 cases of male breast cancer and one papilloma of the male breast. Ki-ras was detected in 50-mu m sections after digestion with proteinase K and SDS. DNA was amplified by polymerase chain reaction, dot blotted, and mutations were screened with labeled ras mutation-specific oligonucleotides. Wild-type and mutant p53 protein were detected with antibodies CM1 and DO7, using the avidin-biotin-perolridase method. Two of 17 carcinomas showed Ki-ras mutations, both in codon 12 (gly --> lys and gly --> arg). Five of 20 male breast cancers (25%), including one large intraductal carcinoma, expressed mutant p53 protein. Although the incidence of mutant p53 expression in male breast cancer is similar to that in women, Ki-ras mutations are not significantly increased.
引用
收藏
页码:367 / 370
页数:4
相关论文
共 50 条
  • [31] p53 polymorphisms and haplotypes in breast cancer
    Sjalander, A
    Birgander, R
    Hallmans, G
    Cajander, S
    Lenner, P
    Athlin, L
    Beckman, G
    Beckman, L
    CARCINOGENESIS, 1996, 17 (06) : 1313 - 1316
  • [32] p53 haplotype determination in breast cancer
    Weston, A
    Pan, CF
    Ksieski, HB
    Wallenstein, S
    Berkowitz, GS
    Tartter, PI
    Bleiweiss, IJ
    Brower, ST
    Senie, TR
    Wolff, MS
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997, 6 (02) : 105 - 112
  • [33] Overexpression of p53 in human breast cancer
    Minguillon, C
    Heinze, T
    Schönborn, I
    Lichtenegger, W
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (01): : 13 - 17
  • [34] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [35] P53 MUTATIONS IN BREAST-CANCER
    COLES, C
    CONDIE, A
    CHETTY, U
    STEEL, CM
    EVANS, HJ
    PROSSER, J
    CANCER RESEARCH, 1992, 52 (19) : 5291 - 5298
  • [36] Serum p53 antibody in breast cancer
    Yamamoto, Shinya
    Chishima, Takashi
    Adachi, Shouko
    Harada, Fumi
    Toda, Youko
    Arioka, Hitoshi
    Hasegawa, Naoki
    Kakuta, Yukio
    CANCER BIOMARKERS, 2014, 14 (04) : 203 - 206
  • [37] p53 polymorphism in ovarian and breast cancer
    Campbell, IG
    Eccles, DM
    Dunn, B
    Davis, M
    Leake, V
    LANCET, 1996, 347 (8998): : 393 - 394
  • [38] p53 as a mutagen test in breast cancer
    Hill, KA
    Sommer, SS
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2002, 39 (2-3) : 216 - 227
  • [39] P53 PROTEIN OVEREXPRESSION IN MALE BREAST-CANCER - CLINICOPATHOLOGICAL (CPC) CORRELATION
    WIECZOREK, R
    HELLER, P
    FEINER, H
    SIDHU, G
    DEMOPOULOS, R
    JAGIRDAR, J
    KLEINBERG, D
    FELDMAN, M
    SUHRLAND, M
    LABORATORY INVESTIGATION, 1994, 70 (01) : A24 - A24
  • [40] COMPARATIVE-ANALYSIS OF MUTATIONS IN THE P53 AND K-RAS GENES IN PANCREATIC-CANCER
    BERROZPE, G
    SCHAEFFER, J
    PEINADO, MA
    REAL, FX
    PERUCHO, M
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) : 185 - 191